Latest disclosed round
Series B
- Date
- 2022-03-07
- Amount
- GBP 50m
- Sector
- Biotech & techbio
- Companies House
- 10269808
Series B
Microbiome-based Live Bacterial Therapeutics
Latest disclosed round
Evidence status
Capital network
Funding record
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2022-03-07 | Series B | £50M | Flerie Invest, Tencent, British Patient Capital, Cambridge Innovation Capital, IP Group, Seventure Partners |
| 2016-12-15 | Seed | £8M | IP Group, Cambridge Innovation Capital |
Traceability
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.